**Background**
Prostatic hyperplasia is a common condition characterized by the enlargement of the prostate gland, which often leads to lower urinary tract symptoms and impaired voiding. The $\alpha_1$-adrenergic receptors play a critical role in regulating the smooth muscle tone of the prostate and bladder neck. Consequently, targeting these receptors is a primary strategy for alleviating urinary obstruction and improving patient quality of life. Beyond urological applications, research has indicated that $\alpha_1$-adrenergic antagonism may influence inflammatory responses and cellular apoptosis in various tissues. In this context, we will introduce an orally active antagonist of the $\alpha_1$-adrenergic receptor – Tamsulosin.
**Definition**
Tamsulosin is an $\alpha_1$-adrenergic receptor antagonist that exhibits high potency across multiple subtypes, including an $\text{EC}_{50}$ of 0.13 nM at the human $\alpha_{1\text{B}}$ receptor in CHO-K1 cells and $\text{IC}_{50}$ values ranging from 1.4 to 4.8 nM at $\alpha_{1\text{D}}$, $\alpha_{1\text{A}}$, and $\alpha_{1\text{B}}$ receptors in HEK293 cells.
**In Vitro and In Vivo Studies**
The Tamsulosin description identifies it as the (R)-(-)-YM12617 free base with a molecular formula of $\text{C}_{20}\text{H}_{28}\text{N}_2\text{O}_5\text{S}$. Regarding Tamsulosin in vitro activity, treatment of human glomerular endothelial cells (GECs) with 25 and 50 nM for 24 hours attenuated high glucose-induced injury by reducing the expression of pro-inflammatory cytokines (IL-6, TNF-$\alpha$, and IL-8), decreasing MMP-2 and MMP-9, and preventing the expression of VCAM-1 and ICAM-1. Western blot analysis further revealed a 2.7- and 1.9-fold decrease in nuclear NF-$\kappa\text{B}$ p65 at 25 and 50 nM, respectively. Additionally, Tamsulosin (1-100 $\mu\text{M}$ for 5 days) influenced ECM production and cellular metabolism in ARPE 19 cells, while concentrations of 50-400 $\mu\text{M}$ for 24 hours induced apoptosis and clusterin expression in NRP-152 cells.
Tamsulosin In Vivo studies have demonstrated diverse biological effects. In mice, administration of 0.001-1 mg/kg via gavage facilitated depressive-like behaviors through endogenous glucocorticoids. In rats with cyclophosphamide-induced overactive bladder, oral doses of 0.01-1 mg/kg for 14 consecutive days inhibited neuronal activation in voiding centers. Furthermore, oral administration of 17.5-35 $\mu\text{g/kg/d}$ provided protection against respiratory inflammatory events in airway sensitization models. For researchers seeking Tamsulosin technical information, these results highlight its utility in studying both urological and systemic inflammatory pathways. In conclusion, Tamsulosin is a potent $\alpha_1$-adrenergic receptor antagonist with significant applications in prostatic hyperplasia and inflammation research.
Keywords
Tamsulosin, 106133-20-4, (R)-(-)-YM12617, LY253351, LY 253351, LY-253351, Adrenergic Receptor, Apoptosis, Beta Receptor, prostatic, hyperplasia, aortic, aneurysm, abdominal, receptors
References
[1] Christopher Chapple, et al. Tamsulosin: an overview. World J Urol. 2002 Apr;19(6):397-404.
[2] Rak A, et al. Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α1-adrenergic receptor antagonist with uro-selective activity. Bioorg Med Chem. 2016 Nov 1;24(21):5582-5591.
[3] Sun L, et al. Tamsulosin attenuates high glucose- induced injury in glomerular endothelial cells. Bioengineered. 2021 Dec;12(1):5184-5194.
[4] Ida Y, et al. The Selective α1 Antagonist Tamsulosin Alters ECM Distributions and Cellular Metabolic Functions of ARPE 19 Cells in a Concentration-Dependent Manner. Bioengineering (Basel). 2022 Oct 14;9(10):556.
[5] Youm Y H, et al. Apoptosis Induction and Clusterin Expression of NRP-152 Cells by Tamsulosin. Journal of the Korean Continence Society, 2006, 10(2): 132-139.
[6] Kim SE, et al. Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder. Int Neurourol J. 2012 Mar;16(1):13-22.
[7] Alabdali H H, et al. Study the anti-inflammatory effects of tamsulosin by the evaluation of inflammatory cells and lung histopathology in an airway inflammation model in rats. Bulletin of Pharmaceutical Sciences. Assiut, 2023, 46(1): 633-645.
[8] Holanda VAD, et al. Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glucocorticoids. Brain Res Bull. 2022 Jan;178:29-36.